APA (7th ed.) Citation

H, D., SG, B., E, D., J, L., BA, M., WF, W., & G, E. (2013). Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis. ACS medicinal chemistry letters, 4(10), 942. https://doi.org/10.1021/ml400194r

Chicago Style (17th ed.) Citation

H, Deng, Bernier SG, Doyle E, Lorusso J, Morgan BA, Westlin WF, and Evindar G. "Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis." ACS Medicinal Chemistry Letters 4, no. 10 (2013): 942. https://doi.org/10.1021/ml400194r.

MLA (9th ed.) Citation

H, Deng, et al. "Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis." ACS Medicinal Chemistry Letters, vol. 4, no. 10, 2013, p. 942, https://doi.org/10.1021/ml400194r.